Kura Oncology, Inc.
KURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422143
In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Kura Oncology, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 148 | 2 | 142 | −4 |
| Shares | 71.6M | 1.78K | 70.1M | −1.42M (−2.0%) |
| Value | $977.5M | $24.0K | $870.3M | −$107.2M (−11.0%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Kura Oncology, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 1,072,000 | $13.3M | 0.36% |
| Sofinnova Investments, Inc. | 593,561 | $7.37M | 0.45% |
| Tekla Capital Management LLC | 283,281 | $3.52M | 0.13% |
| CI Private Wealth, LLC | 38,500 | $477.8K | 0.00% |
| Kennedy Capital Management, Inc. | 28,395 | $352.4K | 0.01% |
| Altium Capital Management LP | 28,198 | $349.9K | 0.18% |
| Ergoteles LLC | 27,404 | $340.1K | 0.01% |
| Granite Point Capital Management, L.P. | 25,000 | $310.3K | 0.37% |
| Kiwi Wealth Investments Limited Partnership | 22,002 | $273.0K | 0.02% |
| Qube Research & Technologies Ltd | 18,887 | $234.4K | 0.00% |
| Innovis Asset Management LLC | 13,404 | $166.3K | 0.08% |
| Gyon Technologies Capital Management, LP | 9,549 | $118.5K | 0.04% |
| Point72 Middle East FZE | 9,243 | $114.7K | 0.01% |
| Belvedere Trading LLC | 505 | $6.27K | 0.00% |
| Parallax Volatility Advisers, L.P. | 385 | $4.78K | 0.00% |
| Northwestern Mutual Wealth Management Co | 38 | $472 | 0.00% |
| GWM Advisors LLC | 215 | $3 | 0.00% |
Sold out (21)
Institutions that held Kura Oncology, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Deep Track Capital, LP | 3,186,083 | $43.5M |
| Verition Fund Management LLC | 576,240 | $7.87M |
| Integral Health Asset Management, LLC | 500,000 | $6.83M |
| Adage Capital Partners GP, L.L.C. | 425,000 | $5.81M |
| Walleye Capital LLC | 268,074 | $3.66M |
| Woodline Partners LP | 267,683 | $3.66M |
| Two Sigma Investments, LP | 255,139 | $3.48M |
| Wellington Management Group LLP | 125,142 | $1.71M |
| Renaissance Technologies LLC | 124,500 | $1.70M |
| PDT Partners, LLC | 71,810 | $981.0K |
| Trexquant Investment LP | 53,641 | $733.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 53,240 | $727.0K |
| Jump Financial, LLC | 51,241 | $700.0K |
| AlphaCrest Capital Management LLC | 44,375 | $606.0K |
| Walleye Trading LLC | 33,220 | $454.0K |
| Aquatic Capital Management LLC | 25,400 | $347.0K |
| DekaBank Deutsche Girozentrale | 24,900 | $327.0K |
| Guggenheim Capital LLC | 21,770 | $297.0K |
| Point72 Hong Kong Ltd | 15,754 | $215.0K |
| Gsa Capital Partners LLP | 14,497 | $198.0K |
| Panagora Asset Management Inc | 11,590 | $158.0K |
Not filed for Q4 2022 yet (2)
Institutions that held Kura Oncology, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| FourThought Financial, LLC | 1,352 | $18.0K |
| Wipfli Financial Advisors LLC, | 424 | $6.00K |